[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 1264 Introduced in Senate (IS)]
<DOC>
118th CONGRESS
1st Session
S. 1264
To amend title XVIII of the Social Security Act to strengthen the drug
pricing reforms in the Inflation Reduction Act.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
April 25, 2023
Ms. Klobuchar (for herself, Mr. Welch, Mrs. Gillibrand, Mr. Heinrich,
Mr. Merkley, Ms. Stabenow, Mr. Reed, Mr. Whitehouse, Mr. Blumenthal,
Ms. Cortez Masto, Ms. Hassan, Mr. King, Ms. Cantwell, Mrs. Shaheen, Ms.
Baldwin, Mr. Durbin, Mr. Brown, Mr. Booker, Ms. Smith, Ms. Warren, Mrs.
Murray, Mr. Cardin, Mr. Markey, and Ms. Duckworth) introduced the
following bill; which was read twice and referred to the Committee on
Finance
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to strengthen the drug
pricing reforms in the Inflation Reduction Act.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Strengthening Medicare and Reducing
Taxpayer Prices Act'' or the ``SMART Prices Act''.
SEC. 2. REPEAL OF THE MEDICARE PART D NONINTERFERENCE CLAUSE.
Section 1860D-11 of the Social Security Act (42 U.S.C. 1395w-111)
is amended by striking subsection (i).
SEC. 3. IMPROVEMENTS TO THE MEDICARE DRUG PRICE NEGOTIATION PROGRAM.
(a) Acceleration of the Selection of Negotiation-Eligible Drugs.--
(1) In general.--Section 1192(a) of the Social Security Act
(42 U.S.C. 1320f-1(a)) is amended--
(A) in paragraph (1)--
(i) by striking ``10'' and inserting
``20''; and
(ii) by inserting ``and'' after the
semicolon at the end;
(B) by striking paragraph (2) and redesignating
paragraph (3) as paragraph (2);
(C) in paragraph (2), as redesignated by
subparagraph (B) of this paragraph--
(i) by striking ``2028, 15 negotiation-
eligible drugs'' and inserting ``2027 or a
subsequent year, 40 negotiation-eligible
drugs''; and
(ii) by striking ``; and'' at the end and
inserting a period; and
(D) by striking paragraph (4).
(2) Conforming amendments.--Section 1192 of the Social
Security Act (42 U.S.C. 1320f-1) is amended--
(A) in subsection (b)(2)--
(i) in the paragraph heading, by striking
``and 2027''; and
(ii) by striking ``and with respect to the
initial price applicability year 2027''; and
(B) in subsection (d)(1), in the matter preceding
subparagraph (A), by striking ``or 2027''.
(b) Improvements to the Definition of Qualifying Single Source
Drug.--Section 1192(e)(1) of the Social Security Act (42 U.S.C. 1320f-
1(e)(1)) is amended--
(1) in subparagraph (A)(ii), by striking ``7 years'' and
inserting ``3 years''; and
(2) in subparagraph (B)(ii), by striking ``11 years'' and
inserting ``3 years''.
(c) Improvement to the Ceiling for Maximum Fair Price.--Section
1194(c)(3) of the Social Security Act (42 U.S.C. 1320f-3(c)(3)) is
amended--
(1) in subparagraph (A), by striking ``75 percent'' and
inserting ``76 percent'';
(2) in subparagraph (B), by striking ``65 percent'' and
inserting ``55 percent''; and
(3) in subparagraph (C), by striking ``40 percent'' and
inserting ``30 percent''.
<all>